ResMed Inc. which can be found using ticker (RMD) now have 9 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 280 and 229 suggesting an average Analsyt target price of $258.00. Now with the previous closing price of $233.50 and the analysts are correct then we can expect a percentage increase in value of 10.5%. The 50 day MA is $221.70 while the 200 day moving average is $222.11. The market capitalization for the company is 34.16B. The stock price for the company is currently is currently 232.49 USD
The potential market cap would be $37,744,229,646 based on the market consensus.
USD
The company has a dividend yield of 2.05%. Other points of data to note are a P/E ratio of 39.67, revenue per share of 27.39 and a 12.06% return on assets.
